These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 2145593)

  • 1. Do functional relationships exist between 5-HT1A and 5-HT2 receptors?
    Darmani NA; Martin BR; Pandey U; Glennon RA
    Pharmacol Biochem Behav; 1990 Aug; 36(4):901-6. PubMed ID: 2145593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.
    Berendsen HH; Broekkamp CL
    Br J Pharmacol; 1990 Nov; 101(3):667-73. PubMed ID: 2150180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants.
    Berendsen HH; Broekkamp CL
    Psychopharmacology (Berl); 1991; 105(2):219-24. PubMed ID: 1839064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
    Bagdy G; Sved AF; Murphy DL; Szemeredi K
    Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated administration of low doses of cocaine enhances the sensitivity of 5-HT2 receptor function.
    Darmani NA; Martin BR; Glennon RA
    Pharmacol Biochem Behav; 1992 Mar; 41(3):519-27. PubMed ID: 1584831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the 5-HT1C receptor-mediated behavior by 5-HT2, but not 5-HT1A, receptor activation.
    Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1992; 44(5):427-36. PubMed ID: 1363616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat.
    Bervoets K; Millan MJ; Colpaert FC
    Eur J Pharmacol; 1990 Nov; 191(2):185-95. PubMed ID: 2150818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT2/5-HT1C receptor-mediated facilitatory action on unit activity of ventral horn cells in rat spinal cord slices.
    Yamazaki J; Fukuda H; Nagao T; Ono H
    Eur J Pharmacol; 1992 Sep; 220(2-3):237-42. PubMed ID: 1358651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of endogenous aspartate from rat cerebellum slices and synaptosomes: inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype.
    Maura G; Barzizza A; Folghera S; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):229-36. PubMed ID: 1830929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural profiles of putative 5-hydroxytryptamine receptor agonists and antagonists in developing rats.
    Jackson HC; Kitchen I
    Neuropharmacology; 1989 Jun; 28(6):635-42. PubMed ID: 2526930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors.
    Backus LI; Sharp T; Grahame-Smith DG
    Br J Pharmacol; 1990 Aug; 100(4):793-9. PubMed ID: 2145051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor subtypes mediating facilitation by serotonin of excitability of spinal motoneurons.
    Jackson DA; White SR
    Neuropharmacology; 1990 Sep; 29(9):787-97. PubMed ID: 2149874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relation of central 5-HT1A and 5-HT2 receptors: low dose agonist-induced selective tolerance in the rat.
    Pranzatelli MR; Pluchino RS
    Pharmacol Biochem Behav; 1991 Jun; 39(2):407-13. PubMed ID: 1835098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M; Lyon RA; Davis KH; Glennon RA
    Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI.
    Arnt J; Hyttel J
    Eur J Pharmacol; 1989 Feb; 161(1):45-51. PubMed ID: 2524390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat.
    Przegaliński E; Budziszewska B; Warchoł-Kania A; Błaszczyńska E
    Pharmacol Biochem Behav; 1989 Jun; 33(2):329-34. PubMed ID: 2530590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Yamada J; Sugimoto Y; Horisaka K
    Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.